These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16187313)

  • 1. C-type natriuretic peptide enhances osteogenic protein-1-induced osteoblastic cell differentiation via Smad5 phosphorylation.
    Yeh LC; Zavala MC; Lee JC
    J Cell Biochem; 2006 Feb; 97(3):494-500. PubMed ID: 16187313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
    Yeh LC; Tsai AD; Zavala MC; Lee JC
    J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.
    Yeh LC; Betchel KP; Lee JC
    J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation.
    Yeh LC; Zavala MC; Lee JC
    J Cell Physiol; 2002 Mar; 190(3):322-31. PubMed ID: 11857448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12.
    Yeh LC; Tsai AD; Lee JC
    J Cell Biochem; 2002; 87(3):292-304. PubMed ID: 12397611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
    Yeh LC; Adamo ML; Olson MS; Lee JC
    Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts.
    Yeh LC; Unda R; Lee JC
    J Cell Physiol; 2000 Oct; 185(1):87-97. PubMed ID: 10942522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of osteogenic protein-1 (OP-1, BMP-7) on bone matrix protein expression by fetal rat calvarial cells are differentiation stage specific.
    Li IW; Cheifetz S; McCulloch CA; Sampath KT; Sodek J
    J Cell Physiol; 1996 Oct; 169(1):115-25. PubMed ID: 8841428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms.
    Yeh LC; Adamo ML; Duan C; Lee JC
    J Cell Physiol; 1998 Apr; 175(1):78-88. PubMed ID: 9491783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
    Kaneki H; Kurokawa M; Ide H
    J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis.
    Erlacher L; McCartney J; Piek E; ten Dijke P; Yanagishita M; Oppermann H; Luyten FP
    J Bone Miner Res; 1998 Mar; 13(3):383-92. PubMed ID: 9525338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
    Singhatanadgit W; Salih V; Olsen I
    Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of carnosine on runt-related transcription factor-2/core binding factor alpha-1 and Sox9 expressions of human periodontal ligament cells.
    Ito-Kato E; Suzuki N; Maeno M; Takada T; Tanabe N; Takayama T; Ito K; Otsuka K
    J Periodontal Res; 2004 Jun; 39(3):199-204. PubMed ID: 15102049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
    Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of combined and sequential bone morphogenetic protein administration.
    Arosarena OA; Puleo D
    Arch Facial Plast Surg; 2007; 9(4):242-7. PubMed ID: 17638757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
    Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal compressive force induces bone formation via increasing bone morphogenetic proteins production and decreasing their antagonists production by Saos-2 cells.
    Mitsui N; Suzuki N; Maeno M; Yanagisawa M; Koyama Y; Otsuka K; Shimizu N
    Life Sci; 2006 May; 78(23):2697-706. PubMed ID: 16337660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.